Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical therapies for vulvodynia
NCT02099006Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Nov 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline, baclofen, Ketofen, ketamine transdermal patch, topical loperamide in vulvodynia, sponsored by University of Rochester. Started Nov 2013; status: completed.
02
Drugs
amitriptylinebaclofenKetofenketamine transdermal patchtopical loperamide
03
Conditions
vulvodynia
Beyond the preview
Go deeper on NCT02099006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099006.